<?xml version="1.0" encoding="UTF-8"?>
<p id="par0270">
 <italic>In vitro</italic>, remdesivir showed potent antiviral activity against both Malaysian and Bangladesh genotypes of Nipah virus and reduced replication of Nipah virus Malaysia in primary human lung microvascular endothelial cells by more than four orders of magnitude, warranting further testing of the efficacy of remdesivir against Nipah virus infection 
 <italic>in vivo</italic>. In contrast, to control animals, which all succumbed to the infection, all remdesivir-treated animals survived the lethal challenge, indicating that remdesivir represents a promising antiviral treatment for Nipah virus infection also 
 <xref rid="bib0855" ref-type="bibr">[171]</xref>.
</p>
